Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 512

1.

IgG4-related disease presenting with combined pulmonary fibrosis and emphysema (CPFE).

Kono M, Nakamura Y, Oyama Y, Saito G, Koyanagi Y, Miyashita K, Tsutsumi A, Enomoto Y, Kobayashi T, Miki Y, Hashimoto D, Enomoto N, Colby TV, Suda T, Nakamura H.

Respir Med Case Rep. 2018 Oct 3;25:257-260. doi: 10.1016/j.rmcr.2018.09.017. eCollection 2018.

2.

Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis.

Suzuki Y, Yoshimura K, Enomoto Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T.

Sci Rep. 2018 Sep 19;8(1):14074. doi: 10.1038/s41598-018-32478-z.

3.

IL-17A Attenuates IFN-λ Expression by Inducing Suppressor of Cytokine Signaling Expression in Airway Epithelium.

Niwa M, Fujisawa T, Mori K, Yamanaka K, Yasui H, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suzuki T, Maekawa M, Suda T.

J Immunol. 2018 Oct 15;201(8):2392-2402. doi: 10.4049/jimmunol.1800147. Epub 2018 Sep 17.

PMID:
30224514
4.

Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis.

Karayama M, Inui N, Tanaka K, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Suda T.

Med Oncol. 2018 Sep 5;35(11):139. doi: 10.1007/s12032-018-1199-z.

PMID:
30187148
5.

Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis.

Suzuki Y, Shirai M, Asada K, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Shirai T, Hayakawa H, Suda T.

Sci Rep. 2018 Sep 3;8(1):13129. doi: 10.1038/s41598-018-31565-5.

6.

Differences in airway structural changes assessed by three-dimensional computed tomography in asthma and asthma-COPD overlap.

Niwa M, Fujisawa T, Karayama M, Furuhashi K, Mori K, Hashimoto D, Yasui H, Suzuki Y, Hozumi H, Enomoto N, Nakamura Y, Inui N, Suda T.

Ann Allergy Asthma Immunol. 2018 Aug 20. pii: S1081-1206(18)30666-5. doi: 10.1016/j.anai.2018.08.006. [Epub ahead of print]

PMID:
30138669
7.

An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases.

Tsuchiya K, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T.

Intern Med. 2018 Aug 10. doi: 10.2169/internalmedicine.1062-18. [Epub ahead of print]

8.

[Infection status of Helicobacter pylori with antibody values of 3.0U/mL or more and less than 10.0U/mL in the LZ test "Eiken" H. pylori antibody].

Miura M, Ohtaka M, Hanawa M, Kitahashi A, Hirose Y, Takaso K, Yoda Y, Takayama I, Yamagata Z, Enomoto N.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(8):721-731. doi: 10.11405/nisshoshi.115.721. Japanese.

PMID:
30101873
9.

Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data.

Ichikawa S, Motosugi U, Enomoto N, Onishi H.

Eur Radiol. 2018 Jul 24. doi: 10.1007/s00330-018-5640-7. [Epub ahead of print]

PMID:
30043162
10.

Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct-acting antivirals for hepatitis C virus.

Yasui Y, Kurosaki M, Komiyama Y, Takada H, Tamaki N, Watakabe K, Okada M, Wang W, Shimizu T, Kubota Y, Higuchi M, Takaura K, Tsuchiya K, Nakanishi H, Takahashi Y, Itakura J, Enomoto N, Izumi N.

Hepatol Res. 2018 Jul 20. doi: 10.1111/hepr.13233. [Epub ahead of print]

PMID:
30030872
11.

LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.

Enomoto Y, Matsushima S, Shibata K, Aoshima Y, Yagi H, Meguro S, Kawasaki H, Kosugi I, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Suda T, Iwashita T.

Clin Sci (Lond). 2018 Jul 31;132(14):1565-1580. doi: 10.1042/CS20180435. Print 2018 Jul 31.

PMID:
30006483
12.

The "real-world" efficacy and safety of DAAs for the treatment of HCV patients throughout Japan.

Maekawa S, Enomoto N.

J Gastroenterol. 2018 Oct;53(10):1168-1169. doi: 10.1007/s00535-018-1493-8. Epub 2018 Jul 6. No abstract available.

PMID:
29980847
13.

Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis.

Kato S, Inui N, Hakamata A, Suzuki Y, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T.

Respir Res. 2018 Jun 26;19(1):127. doi: 10.1186/s12931-018-0831-y.

14.

Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.

Hozumi H, Oyama Y, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T.

PLoS One. 2018 Jun 21;13(6):e0199659. doi: 10.1371/journal.pone.0199659. eCollection 2018.

15.

Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.

Takada H, Kurosaki M, Nakanishi H, Takahashi Y, Itakura J, Tsuchiya K, Yasui Y, Tamaki N, Takaura K, Komiyama Y, Higuchi M, Kubota Y, Wang W, Okada M, Enomoto N, Izumi N.

PLoS One. 2018 Jun 18;13(6):e0198812. doi: 10.1371/journal.pone.0198812. eCollection 2018.

16.

Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study.

Nishimoto K, Karayama M, Inui N, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inami N, Matsuura S, Kaida Y, Matsui T, Asada K, Matsuda H, Fujii M, Toyoshima M, Imokawa S, Suda T.

Med Oncol. 2018 Jun 16;35(7):108. doi: 10.1007/s12032-018-1172-x.

PMID:
29909581
17.

Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon-assisted endoscopy.

Iwamoto F, Matsuoka K, Motobayashi M, Takenaka K, Kuno T, Tanaka K, Tsukui Y, Kobayashi S, Yoshida T, Fujii T, Saito E, Yamaguchi T, Nagahori M, Sato T, Ohtsuka K, Enomoto N, Watanabe M.

J Gastroenterol Hepatol. 2018 Jun 11. doi: 10.1111/jgh.14310. [Epub ahead of print]

PMID:
29889986
18.

Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease.

Yasui H, Inui N, Fujisawa T, Karayama M, Enomoto N, Nakamura Y, Kuroishi S, Ohba H, Yokomura K, Sato J, Sato M, Koshimizu N, Toyoshima M, Yamada T, Masuda M, Shirai T, Suda T.

Clin Med Insights Circ Respir Pulm Med. 2018 May 7;12:1179548418771702. doi: 10.1177/1179548418771702. eCollection 2018.

19.

Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.

Enomoto N, Oyama Y, Enomoto Y, Mikamo M, Karayama M, Hozumi H, Suzuki Y, Kono M, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T.

Clin Respir J. 2018 Aug;12(8):2378-2389. doi: 10.1111/crj.12918.

PMID:
29873202
20.

Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease.

Yoshimura K, Suzuki Y, Inoue Y, Nishimoto K, Mori K, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Imokawa S, Suda T.

PLoS One. 2018 Jun 5;13(6):e0198479. doi: 10.1371/journal.pone.0198479. eCollection 2018.

21.

Posttraumatic Cerebrospinal Fluid Leak Associated with an Upper Cervical Meningeal Diverticulum.

Enomoto N, Mure H, Okazaki T, Azumi M, Okita S, Nagahiro S, Takagi Y.

World Neurosurg. 2018 Aug;116:50-55. doi: 10.1016/j.wneu.2018.05.061. Epub 2018 May 17.

PMID:
29777885
22.

Postprocedural LGE-CMR comparison of laser and radiofrequency ablation lesions after pulmonary vein isolation.

Figueras I Ventura RM, Mǎrgulescu AD, Benito EM, Alarcón F, Enomoto N, Prat-Gonzalez S, Perea RJ, Borràs R, Chipa F, Arbelo E, Tolosana JM, Brugada J, Berruezo A, Mont L.

J Cardiovasc Electrophysiol. 2018 Aug;29(8):1065-1072. doi: 10.1111/jce.13616. Epub 2018 May 21.

PMID:
29722466
23.

Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia.

Yoshimura K, Kono M, Enomoto Y, Nishimoto K, Oyama Y, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Sumikawa H, Johkoh T, Colby TV, Sugimura H, Suda T.

Respir Med. 2018 Apr;137:167-175. doi: 10.1016/j.rmed.2018.02.024. Epub 2018 Mar 1.

PMID:
29605201
24.

[Case of main duct-intraductal papillary mucinous carcinoma (pancreatobiliary type) causing 4-mm dilatation of the pancreatic duct].

Imagawa N, Fukasawa M, Takahashi E, Shindo H, Takano S, Sato T, Kawaida H, Fujii H, Nakazawa T, Enomoto N.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(3):305-312. doi: 10.11405/nisshoshi.115.305. Japanese.

PMID:
29526983
25.

Podoplanin-positive myofibroblasts: a pathological hallmark of pleuroparenchymal fibroelastosis.

Enomoto Y, Matsushima S, Meguro S, Kawasaki H, Kosugi I, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Suda T, Iwashita T.

Histopathology. 2018 Jun;72(7):1209-1215. doi: 10.1111/his.13494. Epub 2018 Mar 25.

PMID:
29468722
26.

[A Case of Gallbladder Carcinoma Producing Alpha-Fetoprotein(AFP)with Metastatic Liver Tumor].

Takahashi H, Suzuki Y, Higuchi K, Yoshinouchi S, Enomoto N, Yoshida T, Ohno R, Mutoh M, Hirokawa K.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1182-1184. Japanese.

PMID:
29394574
27.

Neutrophil gelatinase-associated lipocalin in patients with sarcoidosis.

Kato S, Inui N, Hozumi H, Inoue Y, Yasui H, Karayama M, Kono M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T.

Respir Med. 2018 May;138S:S20-S23. doi: 10.1016/j.rmed.2018.01.004. Epub 2018 Jan 11.

PMID:
29373174
28.

Respiratory impedance is correlated with airway narrowing in asthma using three-dimensional computed tomography.

Karayama M, Inui N, Mori K, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T.

Clin Exp Allergy. 2018 Mar;48(3):278-287. doi: 10.1111/cea.13083. Epub 2018 Feb 5.

PMID:
29315896
29.

Ledipasvir-sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection.

Asahina Y, Itoh Y, Ueno Y, Matsuzaki Y, Takikawa Y, Yatsuhashi H, Genda T, Ikeda F, Matsuda T, Dvory-Sobol H, Jiang D, Massetto B, Osinusi AO, Brainard DM, McHutchison JG, Kawada N, Enomoto N.

Liver Int. 2018 Sep;38(9):1552-1561. doi: 10.1111/liv.13685. Epub 2018 Jun 29.

PMID:
29297980
30.

Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization.

Yasui Y, Tsuchiya K, Kurosaki M, Takeguchi T, Takeguchi Y, Okada M, Wang W, Kubota Y, Goto T, Komiyama Y, Higuchi M, Takaura K, Hayashi T, Takada H, Tamaki N, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Enomoto N, Himeno Y, Izumi N.

Hepatol Res. 2018 May;48(6):442-450. doi: 10.1111/hepr.13048. Epub 2018 Feb 9.

PMID:
29278654
31.

Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study.

Enomoto Y, Nakamura Y, Satake Y, Sumikawa H, Johkoh T, Colby TV, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Iwashita T, Kuroishi S, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yamada T, Shirai T, Hayakawa H, Suda T.

Respir Med. 2017 Dec;133:1-5. doi: 10.1016/j.rmed.2017.11.003. Epub 2017 Nov 6.

PMID:
29173442
32.

Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.

Kumada H, Watanabe T, Suzuki F, Ikeda K, Sato K, Toyoda H, Atsukawa M, Ido A, Takaki A, Enomoto N, Kato K, Alves K, Burroughs M, Redman R, Pugatch D, Pilot-Matias TJ, Krishnan P, Oberoi RK, Xie W, Chayama K.

J Gastroenterol. 2018 May;53(5):689. doi: 10.1007/s00535-017-1409-z.

33.

The prognostic significance of pneumothorax in patients with idiopathic pulmonary fibrosis.

Nishimoto K, Fujisawa T, Yoshimura K, Enomoto Y, Enomoto N, Nakamura Y, Inui N, Sumikawa H, Johkoh T, Colby TV, Suda T.

Respirology. 2018 May;23(5):519-525. doi: 10.1111/resp.13219. Epub 2017 Nov 12.

PMID:
29130562
34.

Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C.

Maekawa S, Sato M, Kuratomi N, Inoue T, Suzuki Y, Tatsumi A, Miura M, Matsuda S, Muraoka M, Nakakuki N, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Sato T, Sakamoto M, Murakawa M, Nakagawa M, Asahina Y, Enomoto N.

J Gastroenterol. 2018 Jun;53(6):780-786. doi: 10.1007/s00535-017-1405-3. Epub 2017 Nov 1.

PMID:
29094205
35.

Ring-Like Enhancement of Hepatocellular Carcinoma in Gadoxetic Acid-Enhanced Multiphasic Hepatic Arterial Phase Imaging With Differential Subsampling With Cartesian Ordering.

Ichikawa S, Motosugi U, Oishi N, Shimizu T, Wakayama T, Enomoto N, Matsuda M, Onishi H.

Invest Radiol. 2018 Apr;53(4):191-199. doi: 10.1097/RLI.0000000000000428.

PMID:
29084013
36.

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.

Kumada H, Watanabe T, Suzuki F, Ikeda K, Sato K, Toyoda H, Atsukawa M, Ido A, Takaki A, Enomoto N, Kato K, Alves K, Burroughs M, Redman R, Pugatch D, Pilot-Matias TJ, Krishnan P, Oberoi RK, Xie W, Chayama K.

J Gastroenterol. 2018 Apr;53(4):566-575. doi: 10.1007/s00535-017-1396-0. Epub 2017 Oct 20. Erratum in: J Gastroenterol. 2017 Nov 13;:.

37.

Endoscopic biliary stenting for unresectable malignant hilar obstruction.

Fukasawa M, Takano S, Shindo H, Takahashi E, Sato T, Enomoto N.

Clin J Gastroenterol. 2017 Dec;10(6):485-490. doi: 10.1007/s12328-017-0778-4. Epub 2017 Oct 19. Review.

PMID:
29052124
38.

Partially covered metal stents have longer patency than uncovered and fully covered metal stents in the management of distal malignant biliary obstruction: a retrospective study.

Yokota Y, Fukasawa M, Takano S, Kadokura M, Shindo H, Takahashi E, Hirose S, Kawakami S, Fukasawa Y, Sato T, Enomoto N.

BMC Gastroenterol. 2017 Oct 11;17(1):105. doi: 10.1186/s12876-017-0662-1.

39.

Persistent impairment on spirometry in chronic eosinophilic pneumonia: A longitudinal observation study (Shizuoka-CEP study).

Suzuki Y, Oyama Y, Hozumi H, Imokawa S, Toyoshima M, Yokomura K, Nakamura H, Kuroishi S, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Koshimizu N, Yamada T, Mori K, Masuda M, Shirai T, Hayakawa H, Sumikawa H, Johkoh T, Suda T.

Ann Allergy Asthma Immunol. 2017 Nov;119(5):422-428.e2. doi: 10.1016/j.anai.2017.08.009. Epub 2017 Sep 21.

PMID:
28942952
40.

Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic Juice.

Takano S, Fukasawa M, Kadokura M, Shindo H, Takahashi E, Hirose S, Maekawa S, Mochizuki K, Kawaida H, Itakura J, Katoh R, Fujii H, Sato T, Enomoto N.

Pancreas. 2017 Nov/Dec;46(10):1281-1287. doi: 10.1097/MPA.0000000000000931.

PMID:
28930868
41.

Relationship between fraction of exhaled nitric oxide and airway morphology assessed by three-dimensional CT analysis in asthma.

Nishimoto K, Karayama M, Inui N, Mori K, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T.

Sci Rep. 2017 Aug 31;7(1):10187. doi: 10.1038/s41598-017-10504-w.

42.

Body size-adjusted dose analysis of pirfenidone in patients with interstitial pneumonia.

Uehara M, Enomoto N, Oyama Y, Suzuki Y, Kono M, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T.

Respirology. 2018 Mar;23(3):318-324. doi: 10.1111/resp.13145. Epub 2017 Aug 29.

PMID:
28851013
43.

Inhibitory effects of metachromin A on hepatitis B virus production via impairment of the viral promoter activity.

Yamashita A, Tamaki M, Kasai H, Tanaka T, Otoguro T, Ryo A, Maekawa S, Enomoto N, de Voogd NJ, Tanaka J, Moriishi K.

Antiviral Res. 2017 Sep;145:136-145. doi: 10.1016/j.antiviral.2017.08.001. Epub 2017 Aug 4.

PMID:
28827084
44.

Histological Grading of Hepatocellular Carcinomas with Intravoxel Incoherent Motion Diffusion-weighted Imaging: Inconsistent Results Depending on the Fitting Method.

Ichikawa S, Motosugi U, Hernando D, Morisaka H, Enomoto N, Matsuda M, Onishi H.

Magn Reson Med Sci. 2018 Apr 10;17(2):168-173. doi: 10.2463/mrms.mp.2017-0047. Epub 2017 Aug 16.

45.

Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Oral Fluoropyrimidine.

Akiyama N, Karayama M, Iwaizumi M, Kusama Y, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T.

Intern Med. 2017 Sep 1;56(17):2367-2371. doi: 10.2169/internalmedicine.8312-16. Epub 2017 Aug 10.

46.

Cinnamic acid derivatives inhibit hepatitis C virus replication via the induction of oxidative stress.

Amano R, Yamashita A, Kasai H, Hori T, Miyasato S, Saito S, Yokoe H, Takahashi K, Tanaka T, Otoguro T, Maekawa S, Enomoto N, Tsubuki M, Moriishi K.

Antiviral Res. 2017 Sep;145:123-130. doi: 10.1016/j.antiviral.2017.07.018. Epub 2017 Aug 2.

PMID:
28780423
47.

Movement of retinal vessels toward the optic nerve head after increasing intraocular pressure in monkey eyes with experimental glaucoma.

Kuroda A, Enomoto N, Ishida K, Shimazawa M, Noguchi T, Horai N, Onoe H, Hara H, Tomita G.

Exp Eye Res. 2017 Sep;162:110-115. doi: 10.1016/j.exer.2017.07.012. Epub 2017 Jul 21.

PMID:
28739100
48.

Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.

Hozumi H, Fujisawa T, Enomoto N, Nakashima R, Enomoto Y, Suzuki Y, Kono M, Karayama M, Furuhashi K, Murakami A, Inui N, Nakamura Y, Mimori T, Suda T.

J Rheumatol. 2017 Sep;44(9):1394-1401. doi: 10.3899/jrheum.170373. Epub 2017 Jul 15.

PMID:
28711881
49.

Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease.

Enomoto Y, Nakamura Y, Colby TV, Johkoh T, Sumikawa H, Nishimoto K, Yoshimura K, Matsushima S, Oyama Y, Hozumi H, Kono M, Fujisawa T, Enomoto N, Inui N, Iwashita T, Suda T.

PLoS One. 2017 Jun 30;12(6):e0180283. doi: 10.1371/journal.pone.0180283. eCollection 2017.

50.

Clinical significance of hypoechoic submandibular gland lesions in type 1 autoimmune pancreatitis.

Takano S, Fukasawa M, Kadokura M, Shindo H, Takahashi E, Hirose S, Fukasawa Y, Kawakami S, Sato T, Enomoto N.

World J Gastroenterol. 2017 May 14;23(18):3295-3300. doi: 10.3748/wjg.v23.i18.3295.

Supplemental Content

Loading ...
Support Center